Printer Friendly
The Free Library
14,380,416 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Evolving Embolic Protection Devices Providing Practitioners with More Options.


New Survey by Greystone Associates Examines the Impact on Interventional Therapeutics

AMHERST, N.H. -- For the millions of patients of cardiovascular disease, peripheral artery disease, and related vascular insufficiency conditions, interventional cardiology is a primary therapeutic avenue for alleviating symptoms and improving quality of life. Until recently, practitioners and their patients have had to deal with the uncertainty associated with complications due to procedure-related embolic embolic /em·bol·ic/ (em-bol´ik) pertaining to an embolus or to embolism.

em·bol·ic
adj.
1. Relating to, or caused by an embolus or embolism.

2. Relating to emboly.
 events. For these patients, the evolving capabilities of embolic protection devices (EPD EPD

expected progeny difference.
) have become an essential element in treatment decisions and therapeutic outcomes.

While the evolutionary success of embolic protection devises has been impressive, several issues must be addressed in order for the technology to fully expand beyond SVG (Scalable Vector Graphics) A vector graphics format from the W3C for the Web that is expressed in XML. Introduced in 2001, SVG was designed to become the standard vector format just as GIFs and JPEGs have become the standard bitmaps for the Web. , PCI (1) (Payment Card Industry) See PCI DSS.

(2) (Peripheral Component Interconnect) The most widely used I/O bus (peripheral bus).
, and carotid artery procedures. Promising indications for embolic protection include atrial atrial /atri·al/ (a´tre-al) pertaining to an atrium.

a·tri·al
adj.
Of or relating to an atrium.


Atrial
Having to do with the upper chambers of the heart.
 fibrillation-related embolism embolism

Obstruction of blood flow by an embolus—a substance (e.g., a blood clot, a fat globule from a crush injury, or a gas bubble) not normally present in the bloodstream. Obstruction of an artery to the brain may cause stroke.
 protection and interventional procedures for cerebrovascular cer·e·bro·vas·cu·lar
adj.
Relating to the blood supply to the brain, particularly with reference to pathological changes.



cerebrovascular

pertaining to the blood vessels of the cerebrum or brain.
 defects.

This sector has been marked by a high level of technology acquisition activity, as established players seek to protect their existing franchise and expand product offerings. Several companies are developing novel approaches to EPD that offer unique advantages. These technologies, while in early clinical trial stages, have the potential to influence the direction of future programs and alliance activity.

These findings are contained in a new report that analyzes embolic protection devices and their therapeutic applications. The report is designed to provide readers with a detailed understanding of approved and development-stage embolic protection devices, and the evolving technology and design issues shaping this segment.

More information is available at www.greystoneassociates.org

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 9, 2007
Words:273
Previous Article:Com One Expands Bluetooth(R) Product Line.
Next Article:Universal Power Group Exhibits at 2007 International Consumer Electronics Show.
Topics:



Related Articles
Micro Therapeutics Signs Distribution Agreement With Abbott Laboratories; Abbott Obtains U.S./Canadian Rights for MTI's Peripheral Blood Clot...
Guidant and EMBOL-X Announce International Distribution Agreement for Neuroprotection Products.
Guidant Launches Study to Evaluate New Embolic Protection System.
Setting the context: environmental health practitioner competencies. (Guest Commentary).
Medicare private contracting: increasing patient choice and access? (Health Policy Update).
MRI medical device markers utilizing fluorine-19.(Patent News)
Tiered storage: does all data have to fly first class?(Storage Networking)
Clinical Trial Demonstrates Positive Results for St. Jude Medical Device Treating Coronary Bypass Graft Blockages.
Goodman to Exclusively Distribute Embolic Coils from Micrus Endovascular.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles